Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals

Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022. Following historic success of smallpox vaccination with vaccinia virus (VACV)-based vaccines, the third generation modified vaccinia Ankara (MVA)-based vaccine was used as prophylaxis for MPXV, but its effectiveness rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Hubert, Mathieu, Guivel-Benhassine, Florence, Bruel, Timothée, Porrot, Françoise, Planas, Delphine, Vanhomwegen, Jessica, Wiedemann, Aurélie, Burrel, Sonia, Marot, Stéphane, Palich, Romain, Monsel, Gentiane, Diombera, Harouna, Gallien, Sébastien, Lopez-Zaragoza, Jose Luis, Vindrios, William, Taieb, Fabien, Fernandes-Pellerin, Sandrine, Delhaye, Maurine, Laude, Hélène, Arowas, Laurence, Ungeheuer, Marie-Noelle, Hocqueloux, Laurent, Pourcher, Valérie, Prazuck, Thierry, Marcelin, Anne-Geneviève, Lelièvre, Jean-Daniel, Batéjat, Christophe, Lévy, Yves, Manuguerra, Jean-Claude, Schwartz, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188274/
https://www.ncbi.nlm.nih.gov/pubmed/37196656
http://dx.doi.org/10.1016/j.chom.2023.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188274/
https://www.ncbi.nlm.nih.gov/pubmed/37196656
http://dx.doi.org/10.1016/j.chom.2023.05.001

Ejemplares similares